Barbara Seitz-Polski Selected Research

Barbara Seitz-Polski Research Topics

Disease

22	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2024 - 06/2013
12	COVID-19 11/2023 - 01/2020
8	Proteinuria 01/2021 - 12/2014
5	Infections 11/2023 - 01/2020
5	Neoplasms (Cancer) 01/2022 - 05/2014
5	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 06/2013
4	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2024 - 04/2017
2	Multiple Sclerosis 01/2023 - 09/2016
2	Neuromyelitis Optica (Devic's Disease) 01/2022 - 12/2018
1	Breakthrough Infections 01/2023
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2023
1	Vasculitis (Vasculitides) 01/2023
1	Localized Scleroderma (Morphea) 01/2023
1	Immune System Diseases (Immune Disorders) 01/2022
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022
1	Multiple Myeloma 01/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Central Nervous System Vasculitis 01/2022
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021
1	Cross Infection (Nosocomial Infection) 01/2021
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Chilblains (Chilblain) 01/2021
1	Myasthenia Gravis 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Neutropenia 01/2021
1	Cytokine Release Syndrome 01/2020
1	Albuminuria 01/2020
1	Chronic Kidney Failure (Chronic Renal Failure) 04/2017
1	Hidradenitis Suppurativa 01/2017
1	Nervous System Diseases (Neurological Disorders) 09/2016
1	Pseudotumor Cerebri (Idiopathic Intracranial Hypertension) 09/2016
1	Inflammation (Inflammations) 09/2016
1	Demyelinating Diseases (Demyelinating Disease) 09/2016
1	Kidney Diseases (Kidney Disease) 05/2014

Drug/Important Bio-Agent (IBA)

11	Rituximab (Mabthera)FDA Link 01/2024 - 12/2018
10	AntibodiesIBA 11/2023 - 05/2014
10	Phospholipase A2 ReceptorsIBA 12/2020 - 06/2013
8	AutoantibodiesIBA 12/2020 - 06/2013
7	Biomarkers (Surrogate Marker)IBA 01/2023 - 09/2016
5	AntigensIBA 01/2022 - 05/2014
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2013
5	ThrombospondinsIBA 12/2020 - 12/2014
5	EpitopesIBA 01/2020 - 01/2016
4	VaccinesIBA 01/2023 - 01/2021
4	AutoantigensIBA 12/2020 - 01/2016
3	Immunoglobulin G (IgG)IBA 11/2023 - 12/2014
3	mRNA VaccinesIBA 01/2023 - 01/2021
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2017
2	Immune Checkpoint InhibitorsIBA 09/2023 - 01/2023
2	Serum AlbuminIBA 01/2021 - 01/2018
2	InterferonsIBA 01/2020 - 01/2020
1	Oxygen (Dioxygen)IBA 01/2023
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2023
1	tocilizumab (atlizumab)FDA Link 01/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023
1	SolventsIBA 11/2022
1	AsbestosIBA 11/2022
1	Air Pollutants (Pollutants, Air)IBA 11/2022
1	BNT162 VaccineIBA 01/2022
1	Amino Acids FDA Link 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	KynurenineIBA 01/2022
1	LipidsIBA 01/2022
1	Tryptophan (L-Tryptophan)FDA Link 01/2022
1	Neutralizing AntibodiesIBA 01/2022
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2022
1	COVID-19 VaccinesIBA 01/2021
1	fibrin fragment D (D-dimer)IBA 01/2021
1	CreatineIBA 01/2021
1	NivolumabIBA 01/2021
1	Interferon-alpha (Interferon Alfa)IBA 01/2021
1	Aldehyde Reductase (Aldose Reductase)IBA 12/2020
1	Phosphopyruvate Hydratase (Enolase)IBA 12/2020
1	Immunologic Factors (Immunomodulators)IBA 01/2020
1	CreatinineIBA 01/2020
1	CytokinesIBA 01/2020
1	Immunoglobulin A (IgA)IBA 01/2020
1	Interleukin-8 (Interleukin 8)IBA 01/2020
1	C-Reactive ProteinIBA 01/2017
1	Infliximab (Remicade)FDA Link 01/2017
1	Interleukin-17 (Interleukin 17)IBA 09/2016

Therapy/Procedure

3	Therapeutics 01/2024 - 01/2021
2	Drug Therapy (Chemotherapy) 06/2021 - 01/2021
2	Kidney Transplantation 04/2017 - 12/2014
1	Nursing Care 01/2022
1	Patient Isolation 01/2022
1	Radiotherapy 01/2021
1	Length of Stay 01/2021
1	Precision Medicine 01/2020
1	Transplantation 12/2014